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Abstract The non-heme ferrous dependent oxidase isopenicillin
N synthase (IPNS) catalyses the biosynthesis of isopenicillin N
from a tripeptide substrate. The crystal structure of Aspergillus
nidulans IPNS complexed to manganese reveals a six co-ordinate
metal ligated by two water molecules and four protein ligands:
His-214, His-270, Asp-216 and Gln-330 (the penultimate C-
terminal residue). Modification of Gln-330 to Ala or Leu, or
deletion of 2 or 6 residues from the C-terminus resulted in
lowering of specific activity; no activity was observed after
deletion of 8 residues. The results demonstrate that metal ligation
by Gln-330 is not required for catalytic activity.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
Isopenicillin N synthase (IPNS) catalyses the biosynthesis
of isopenicillin N, the precursor of all other penicillins and
cephalosporins, by the oxidative bicyclisation of the tripep-
tide, L-N-(K-aminoadipoyl)-L-cysteinyl-D-valine (ACV) (see
scheme below). IPNS is a member of an extended family of
non-heme oxidases and oxygenases which all have a require-
ment for ferrous iron [1,2].
Spectroscopic studies have demonstrated the presence of an
aspartyl and two or three histidinyl residues ligating iron at
the active site of IPNS [3]. It has also been suggested that one
of the histidinyl ligands might be displaced upon binding of
ACV [3,4]. The spectroscopic assignments of an aspartyl and
two histidinyl ligands were supported by mutagenesis studies
in the light of comparisons of IPNS sequences with those of
related oxygenases [5,6]. The crystal structure of IPNS (Asper-
gillus nidulans
1
) complexed to manganese substituting for iron
revealed a 6 co-ordinate metal ligated by two water molecules
and four protein ligands: His-270, His-214, Asp-216 and the
unexpected fourth ligand, Gln-330, the penultimate residue on
the C-terminus of IPNS [7].
Comparison of the last eight C-terminus residues of IPNSs
from di¡erent organisms (with the sole exception of IPNS
from Streptomyces cattleya) reveals a region of close similar-
ity, in which the penultimate glutaminyl residue is conserved
(Table 1). The DNA sequence of IPNS from S. cattleya
[Wang, Y. and Li., R., unpublished data (Swissprot database,
accession number D78166)] encodes IPNS with an apparently
truncated C-terminus. If the S. cattleya sequence does indeed
encode a catalytically active IPNS, it would seem likely that
ligation of the active site iron by Gln-330 is not essential for
catalytic activity of IPNS. Herein, we report the results of a
study which explores the importance of Gln-330 for catalytic
activity of IPNS (A. nidulans). The results clearly demonstrate
that neither Gln-330 nor the C-terminal carboxylate of Thr-
331 are essential for catalytic activity.
2. Materials and methods
2.1. Materials
DNA manipulations were carried out essentially according to Sam-
brook et al. [8]. Enzymes for molecular biology were purchased from
Pharmacia, Promega or New England Biolabs. Double-stranded
DNA sequencing was carried out using Sequenase 2.0 according to
the manufacturer's instructions (US Biochemical Corp.).
The original wild-type IPNS (A. nidulans) expression plasmid,
pJB703, used throughout this study was constructed by J.M. Black-
burn, and the expression and growth of clones containing wild-type
and mutant genes were carried out in Escherichia coli strain NM554
as previously described [9].
Site-directed mutagenesis was carried out using the Pharmacia USE
kit according to the manufacturer's instructions. Stop codons were
introduced at residues 323, 325 and 329 to obtain truncations in the
C-terminus or modi¢cations of glutamine were made by substituting
the appropriate codon to attain the desired mutations (Table 1).
The Mcat mutant, in which the C-terminus of IPNS (A. nidulans)
was modi¢ed to that of IPNS (S. cattleya), was constructed by inser-
tion of a synthetic cassette corresponding to the truncated C-terminus
of S. cattleya (forward strand: 5P-GT GAC TAT CTG CAG GAA
GGT TTC ACT CGT TAG-3P ; reverse strand: 5P-CG CGC TAA
CGC GTG AAA CCT TCC TGC AGA TA-3P).
The pJB703 plasmid contains a single HindIII restriction site which
was exchanged with an MluI site using the following selection pri-
mers: HindIII to MluI: 5P-GGC TGC AGC CAC GCG TGG CTG
TTT TGG-3P ; MluI to HindIII: 5P-GCC AAA ACA GCC AAG CTT
GGC TGC AGC C-3P. The appropriate mutagenised region was se-
FEBS 18321 24-10-97
0014-5793/97/$17.00 ß 1997 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 1 7 6 - 2
*Corresponding author (or P.L. Roach or C.J. Schofield).
Fax: (44) (1865) 275674.
Abbreviations: DTT, dithiothreitol ; ACV, L-N-(K-aminoadipoyl)-L-
cysteinyl-D-valine; SDS-PAGE, sodium dodecyl sulphate-polyacryla-
mide gel electrophoresis; IPNS, isopenicillin N synthase.
1
Also known as Emericella nidulans.
Table 1
Synthetic oligonucleotides used for mutagenesis
MutantTarget primer
Q330A 5P-AAC AAG AAC GGC GCT ACC TAG AAG CGA GGG-3P
Q330L 5P-AAC AAG AAC GGC CTG ACC TAG AAG CGA GGG-3P
Q330D 5P-AAC AAG AAC GGC CTG ACC TAG AAG CGA GGG-3P
G329 5P-ATC AAC AAG AAC GGC TAG ACC TAG AAG CGA-3P
I325 5P-CTG GTG AGT TTG ATC TAG AAG AAC GGC CAG-3P
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quenced in both directions by Sanger's dideoxy chain termination
method to verify the speci¢c mutations at the site desired.
Sequence alignments were performed using software from the Ge-
netics Computer Group [10].
2.2. Expression and enzyme puri¢cation
Recombinant cells carrying the wild-type or mutant IPNS (A. ni-
dulans) plasmids were used to inoculate £asks of 2UTY medium
containing 35 Wg/ml chloramphenicol. After overnight growth at
37³C cells were harvested by centrifugation and stored at 380³C.
Two di¡erent puri¢cation procedures were applied depending upon
whether the enzyme was to be used for hole plate (1) or kinetic assays
(2):
(1) Cells were sonicated in lysis bu¡er (50 mM Tris pH 8.0, glycerol
10% w/v, 5 mM EDTA, 0.1% Triton X-100, 0.1% L-mercaptoethanol)
and the crude cell lysate was applied to a 1 ml Resource Q column
(Pharmacia). Fractions were collected from the column using a salt
gradient (20 ml, 0^0.5 M NaCl in 50 mM Tris pH 8.0) and IPNS was
eluted at approx. 150 mM NaCl. All protein-containing fractions were
analysed by SDS-PAGE and the two purest fractions (by SDS-PAGE
analysis) were pooled and desalted using a PD10 column (Pharmacia)
into low salt bu¡er (10 mM Tris pH 8).
(2) IPNS was puri¢ed from crude cell lysate using a three column
puri¢cation protocol as described elsewhere [11].
All protein puri¢cation procedures were performed at 4³C and all
the puri¢ed protein was stored at 380³C with little loss of activity for
up to 6 months.
2.3. Assays for IPNS activity
The speci¢c activities of puri¢ed IPNSs were determined by the hole
plate assay using Staphylococcus aureus N.C.T.C. 6571 as the indica-
tor organism [9]. Apparent K
m
and k
cat
values were determined by
monitoring isopenicillin N production by HPLC analysis. The stand-
ard assay mixture contained in a ¢nal volume of 100 Wl, 2 mM ACV,
4 mM DTT, 1mM ascorbate, 0.10 mM FeSO
4
, 50 mM Tris pH 8.0
and up to 100 WM (3.6 mg/ml) apo-enzyme. The appearance of iso-
penicillin N was linear with respect to time for up to 20 min under the
conditions employed. For kinetic assays by HPLC, incubations were
terminated after 5 min at 28³C by addition of an equal volume of
methanol. The samples were centrifuged for 5 min at 11 000Ug to
remove any denatured protein and analysed immediately by HPLC
or stored at 320³C. HPLC analysis was carried out using an ODS
C18 column (5 Wm, 250 mmU4.6 mm) and the mobile phase for
optimal separation was a gradient of 2.5^45% acetonitrile in 50 mM
potassium phosphate pH 6.8. UV detection was at 220 nm at a sensi-
tivity of 0.04 AUFS. Protein concentrations were determined by the
method of Bradford [12] using BSA as standard. The amount of
isopenicillin N produced in the HPLC assays was quanti¢ed by com-
parison with a standard of synthetic isopenicillin N, calibrated by
1
H-
NMR (500 MHz) analysis.
2.4. Spectroscopy
CD measurements in 50 mM sodium phosphate pH 8.0 at a protein
concentration of 5.3 WM were carried out in a 1 mm path length cell
using a Jasco 720 spectropolarimeter operated at a scan rate of 50 nm/
min in the range 195^250 nm. Mass spectrometric analyses were per-
formed using the electrospray ionisation technique on a BIO-Q Triple
Quad mass spectrometer (VG instruments). Typically, 75^150 pmol of
protein were dissolved in 15 Wl of 50% acetonitrile in water and in-
jected into the electrospray ionisation source. Scans of 3 s were accu-
mulated covering a 800^1500 Da range and spectra were analysed
employing the Mass Lynx 2.0 software (VG organic). Calibrations
were performed separately by the injection of horse heart myoglobin.
3. Results
3.1. Expression and puri¢cation of wild-type IPNS and its
mutants
Overnight growth at 37³C of wild-type or mutant IPNS
cultures resulted in the overexpression of a soluble 36 kDa
protein (approx. 40% of total soluble protein as determined by
SDS-PAGE analysis) as previously reported [9]. Puri¢cation
protocol 1 gave 5^10 mg of protein from 100 ml overnight
culture which was s 90% pure by SDS-PAGE analysis and
was suitable for molecular weight determinations by ESIMS
or for activity determination by hole plate assay. All protein
preparations from three column puri¢cation (protocol 2) re-
sulted in IPNS of s 95% purity as determined by SDS-PAGE
analysis (Fig. 2).
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Fig. 1. Sequence comparison of the C-terminal regions of IPNSs from sequence databases (with accession numbers in parentheses) together
with IPNS mutants. The last row shows identity/similarity of the C-terminus amino acids: totally conserved (bold capitals); signi¢cantly con-
served (capitals); non-conserved residues (lower case). The Gln-330 is also shown in bold. The bar indicates residues which form part of the C-
terminal K-helix (K-10, shaded) and L-sheet (L-16, black) based on the Mn(II) IPNS structure [7].
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3.2. Spectroscopy
The molecular masses from ESIMS of the mutant IPNSs
(A. nidulans) correlated well with the values from the pre-
dicted amino acid sequences (Table 2). Analysis by CD spec-
troscopy showed no signi¢cant di¡erences between wild-type
IPNS (A. nidulans) and either active or inactive mutant en-
zymes (data not shown).
3.3. Hole plate and kinetic assay
Enzyme assays were carried out (at least) in duplicate using
(at least) two di¡erent protein concentrations of each mutant
enzyme with essentially the same results. The Mcat mutant
showed no activity by hole plate assay method (Table 2);
hole plate assays repeated with higher protein concentrations
(up to 100 WM) also failed to show activity with this protein.
The trends in the observed speci¢c activities for the other
IPNS (A. nidulans) mutants from the hole plate assay qual-
itatively correlated well with the HPLC assays (Table 3). The
HPLC assays were carried out (at least) in duplicate on each
mutant IPNS with essentially the same results and the meas-
urements varied no more than 20% between two independ-
ently puri¢ed batches of the same protein. The speci¢c activity
for the recombinant wild-type IPNS (A. nidulans) using the
HPLC assay was somewhat lower than that reported for
IPNS (C. acremonium) enzyme using an oxygen electrode
[13] assay or an ACV consumption assay [5].
4. Discussion
The crystal structure of IPNS complexed to manganese
shows the C-terminal K-helix projecting between two of the
eight L-strands forming the `jelly roll' L-barrel of IPNS. The
eight residues subsequent to the C-terminal helix form a loop
terminating in the conserved (except apparently for the S.
cattelaya IPNS) Gln-330^Thr-331 dipeptide. Ligation of the
cysteinyl thiol of ACV to the active site iron has been dem-
onstrated by spectroscopic studies [14,15]. Analysis of the
IPNS-manganese structure suggests that this cannot occur
without prior displacement of at least one of the four metal
ligands (His-214, Asp-216, His-270, Gln-330). Since the two
histidinyl and aspartyl residues form part of the jelly roll plat-
form of IPNS and are conserved throughout other sequence
related members of the family, we have proposed that the
amide side chain of Gln-330, which is only conserved through
IPNS isozymes, is displaced from the iron during catalysis [7].
The modi¢ed IPNSs in which Gln-330 was substituted by
alaninyl (Q330A) or leucinyl (Q330L) residues display reduced
but substantial catalytic activities of greater than 50% of that
of the wild-type enzyme. Deletion of two C-terminal residues
(G329) also led to an approx. 50% reduction in speci¢c activ-
ity. Hence, ligation of the amide side chain of the glutaminyl
residue to the active site metal is clearly not essential for
catalysis (Tables 2 and 3). Since Gln-330 is the penultimate
residue on the C-terminus of IPNS it is possible that in the
Q330A, Q330L and G329 mutants the role of the amide side
chain of Gln-330 might be ful¢lled by the C-terminal carbox-
ylate. However, a further C-terminally truncated version of
IPNS with six residues deleted (I325) was still active, albeit
with a very much reduced speci¢c activity of only approx.
10% of that of the wild-type enzyme.
In order for the C-terminus of the I325 mutant to reach to
the active site metal (minimally) some unravelling of the C-
terminal K-helix must occur. Since this is unlikely to occur
without a distortion of the structure, the possibility of the
C-terminal carboxylate substituting for the amide side chain
of Gln-330 in the modi¢ed IPNS is ruled out. IPNS (A. nidu-
lans) was also modi¢ed by the deletion of eight residues from
its C-terminus and substitution of four other residues at the
C-terminus (Fig. 1) to give a protein with a similar truncated
C-terminus to that reported for S. cattleya. However, the
resultant hybrid IPNS (Mcat) was completely inactive with
respect to isopenicillin N formation.
CD spectroscopic comparisons of the wild-type, hybrid
IPNS (Mcat) and other modi¢ed IPNSs showed no di¡erences
in secondary structure. Precise reasons for the lack of activity
of the hybrid IPNS (Mcat) are presently unclear. The possi-
bility should be considered that the stop codon apparently
truncating the S. cattleya IPNS sequence is either read
through in vivo or is artefactual; a single base change to
the published S. cattleya IPNS sequence restores a `typical'
C-terminus to the S. cattleya enzyme.
Although we have determined the apparent K
m
and k
cat
values for the wild-type IPNS and three modi¢ed IPNSs,
the interpretation (and accuracy) of the kinetic data is com-
FEBS 18321 24-10-97
Table 3
Apparent kinetic parameters for wild-type IPNS (A. nidulans) and mutants
Enzyme type V
max
(nmol/min per mg) K
m
(mM) k
cat
(min
31
) k
cat
/K
m
(mM
31
min
31
)
Wild type 303 ( þ 30) 1.22 12 9.8
Q330A 144 ( þ 20) 0.72 6 8.3
G329 150 ( þ 12) 0.70 6 8.5
I325 32 ( þ 1) 0.82 1 1.3
Table 2
Hole plate assays and mass spectrometric analyses of IPNS (A. nidulans) and mutants
Enzyme type Calculated
a
molecular mass (Da) Observed molecular mass (Da) Relative speci¢c activities (wild type= 100%)
Wild type 37 391 37 392 ( þ 1) 100
Q330A 37 334 37 335 ( þ 1) 63
Q330L 37 376 37 381 ( þ 2) 100
Q330D 37 378 37 382 ( þ 2) 64
G329 37 161 37 161 ( þ 3) 40
I325 36 748 36 746 ( þ 2) 10
Mcat 36 652 36 653 ( þ 4) 6 0.5
a
Values calculated from translated amino acid sequences based on reported DNA sequences.
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plicated by a number of factors: (1) the lability of the product
with respect to hydrolysis; (2) conversion of the substrate
thiol to its disulphide (a facile process under the incubation
conditions); (3) non-enzymatic consumption of dioxygen
(again signi¢cant under the incubation conditions); (4) inacti-
vation of IPNS (either via `incorrect' reaction of catalytic
intermediates or by Fenton/Udenfriend type reactions); (5)
production of `shunt products' [1]. Nonetheless the prelimi-
nary results based on the analysis of isopenicillin N produc-
tion are intriguing and merit brief discussion.
The apparent K
m
values for ACV for the Q330A, G329 and
I325 modi¢ed IPNSs are all reduced by similar amounts (ap-
prox. 35^45%) relative to the wild-type enzyme. We propose
that the side chain of Gln-330 is displaced from the active site
iron by the thiol of ACV and the observed reductions in K
m
for ACV are consistent with this proposal. Part of the role of
the C-terminus may be to maintain ferrous iron at the active
site under the relatively low iron concentrations (cf. in vitro
incubations) likely to be found in vivo. However, there is also
a clear reduction in k
cat
in the C-terminally modi¢ed IPNSs,
by approx. 50% in the case of the G330A and G329 mutants
and by s 90% in the case of the I325 mutant. These obser-
vations imply a role for the C-terminus in steps subsequent to
iron and ACV binding. One possibility is that the C-terminus
promotes release of the intact penicillin product from the
active site; if the penicillin is allowed to remain at the active
site the iron may promote Lewis acid catalysed fragmentation
of the bicyclic penicillin via complexation to the sulphur of
the thiazolidine ring.
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Fig. 2. Coomassie blue stained SDS-PAGE (12.5% gel) analysis of
puri¢ed mutant and wild-type IPNS (A. nidulans). Lanes from left
to right show 10 Wg of puri¢ed enzymes using protocol 2: (1) wt;
(2) Q330A; (3) G329; (4) I325; (5) molecular weight markers.
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